Company: JUPGF
Filing Date: 2025-09-15
Form Type: F-1
Source: 0001493152-25-013292
Chunk: 151

Company: ATLAS CRITICAL MINERALS Corp
Filing Date: 2025-09-15
Form: F-1
Chunk 151
---
 directors, executive officers and other key employees. The indemnification agreements will require us to
indemnify our directors to the fullest extent permitted by Republic of the Marshall Islands law. We have agreed to indemnify each of
our directors and certain officers against certain liabilities, including liabilities under the Securities Act. Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons pursuant to the
provisions described above, or otherwise, we have been advised that in the opinion of the SEC such indemnification is against public
policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such
liabilities (other than our payment of expenses incurred or paid by our director, officer or controlling person in the successful defense
of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being
registered, we will, unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to a court of
appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act
and will be governed by the final adjudication of such issue.

| 118 |

<div align='center'>SHARES
ELIGIBLE FOR FUTURE SALE</div>

Future sales of substantial
amounts of our common stock in the public market, including shares issued upon the exercise of outstanding options or warrants, or upon
debt conversion, or the anticipation of these sales, could adversely affect market prices prevailing from time to time and could impair
our ability to raise capital through sales of equity securities.

Upon completion of this
offering we estimate that we will have 3,564,843 outstanding shares of our common stock, calculated as of the date of this prospectus,
assuming no further conversions of preferred stock, no exercise of outstanding options or warrants, and no sale of shares reserved for
the underwriters for over-allotment allocation, if any.

Sale of Restricted Securities

The shares of our common
stock sold pursuant to this offering will be registered under the Securities Act, and therefore freely transferable, except for our affiliates.
Our affiliates will be deemed to own “control” securities that are not registered for resale under the registration statement
covering this prospectus. Individuals who may be considered our affiliates after this offering include individuals who control, are controlled
by or are under common control with us, as those terms generally